Evaluation of Therapeutic Adherence Among Patients Followed in the Department of Hereditary Metabolic Diseases at Necker Hospital
Condition(s) studied
Investigational drug(s) / intervention(s)
Questionnaire: A pseudonymized questionnaire assessing treatment adherence, understanding of the illness, knowledge of medications, and the number of oral medications taken is given to patients and/or their parents during a follow-up visit, whether in a consultation, day hospital, or conventional hospitalization. It is completed by parents and children aged 7 and older, as well as by adolescents and young adults. The responses will not be disclosed to the physicians in the department.
Calculation of the metabolic balance score: For patients with urea cycle deficiency, a metabolic balance score will be calculated independently from retrospective data from the medical record, in the last two years preceding the completion of the questionnaire.
Study summary
The purpose of this study is to evaluate treatment adherence among patients followed in the Department of Inherited Metabolic Diseases at Necker Hospital, in order to assess the need for implementing a therapeutic education workshop focused on medication adherence.
Eligibility
Primary outcome measure(s)
- Assessment of therapeutic adherence — Time 0
Therapeutic adherence score, established from the declarations of patients and their parents to the study questionnaire.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Necker-Enfants Malades | Paris | France | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07356557 on ClinicalTrials.gov ↗ ← All trials in France